COMPOUND OVERVIEW

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. Composed of 15 amino acids, BPC-157 has emerged as one of the most extensively studied peptides in regenerative and healing research. Its remarkable stability in the gastric environment and its demonstrated effects across multiple tissue types — including tendon, ligament, muscle, bone, neural tissue, and gastrointestinal mucosa — have made it a cornerstone compound in peptide research. BPC-157 appears to operate through multiple converging pathways, making it uniquely versatile among research peptides.

MECHANISM OF ACTION

BPC-157 exerts its effects through several interconnected mechanisms. It upregulates growth hormone receptor expression in target tissues, enhances nitric oxide (NO) synthesis and angiogenesis, and modulates the expression of growth factors including VEGF and EGF. It demonstrates significant interaction with the dopaminergic and serotonergic systems in the CNS, and has been shown to activate the FAK-paxillin pathway involved in cell survival and migration. Its cytoprotective activity in the GI tract is attributed to stabilization of the intestinal mucosal barrier and stimulation of prostaglandin release.

RESEARCH APPLICATIONS

• Tendon, ligament, and musculoskeletal tissue repair research
• Gastrointestinal healing and gut mucosal integrity studies
• Neurological and brain injury protection research
• Angiogenesis and wound healing models
• Inflammatory response and immune modulation studies
• Bone healing and osteogenesis research
• Systemic cytoprotection and organ protection models

KEY RESEARCH FINDINGS

• Research in rat models demonstrated accelerated tendon-to-bone healing with BPC-157 administration following surgical transection
• Studies have shown reduction of gastric ulcer formation and acceleration of mucosal repair in GI research models
• Neurological research indicates protective effects on dopaminergic neurons and partial reversal of opioid-induced damage in animal models
• Multiple studies have demonstrated angiogenic activity, with BPC-157 promoting capillary formation in wound models
• Research in ligament injury models showed significantly faster tensile strength recovery with BPC-157 versus control groups
• Anti-inflammatory effects confirmed across multiple in vivo models, including NSAID-induced intestinal damage

STORAGE & HANDLING

• Store lyophilized powder at -20°C; stable for up to 24 months
• Reconstitute with bacteriostatic water; stable at 2–8°C for up to 28 days post-reconstitution
• Avoid repeated freeze-thaw cycles after reconstitution
• Protect from heat and light
• Handle under sterile conditions in a suitable research setting

SPECIFICATIONS

DISCLAIMER: This compound is sold strictly for laboratory and research purposes only. It is not intended for human consumption, clinical use, or veterinary application. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. For use by licensed researchers and qualified professionals only. You must be 21 years of age or older to purchase.

usaminopeptides.com · For Researcher Inquiries Contact: info@usaminopeptides.com